Michel Habib

Mr. Michel Habib is a seasoned venture capitalist and senior executive investing in MedTech & Biotech. He’s an expert in value building throughout the whole spectrum of tech companies’ development, with a track record of successful exits of over 1.5 $Bn through M&A and IPOs. Founder, Managing General Partner at ALIVE VC fund, a $150M Healthtech fund launched in mid-2020, Advisor to CBG Ltd, a multi-billion family office, and former CEO of Hadasit Bio-Holdings (HDST). He serves on the BoD of Enlivex (merged on Nasdaq), Kahr Medical, Minovia, Eximore, TPCera, Epitomee, Meditate, PI Therapeutics, Xenia Ventures and VLX Incubator, served as Chairman and on the BOD of Cellcure, acquired by Biotime (LCTX). Former Venture Partner at Agate Medical Investments and Managing General Partner at MaC LP VC Funds, with over $100M under management, with significant exits (Lumenis, MST, Endochoice, Peptron). Former Elron’s BD Director, managing the Medical Devices sector (Medingo, Given Imaging, Brainsgate).

Mr. Habib established and managed the Israel investment banking activity of ING Barings and served as VP Investment Banking at Cukierman & Co. During the 90’s, he also served as Economic Consul in Boston and as Commercial Attaché to South Korea. Mr. Habib holds a BsC in Aeronautical Engineering from the Technion.